Corvus Pharmaceuticals, Inc. (CRVS)
20.40
-0.06
(-0.29%)
USD |
NASDAQ |
Feb 09, 16:00
20.06
-0.34
(-1.67%)
After-Hours: 18:39
Corvus Pharmaceuticals Shareholders Equity (Quarterly) : 71.77M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Plus Therapeutics, Inc. | 5.054M |
| Geron Corp. | 248.71M |
| Jaguar Health, Inc. | 5.627M |
| Krystal Biotech, Inc. | 1.138B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 80.47M |
| Total Liabilities (Quarterly) | 8.706M |
| Debt to Equity Ratio | 0.0141 |
| Current Ratio | 8.291 |
| Net Debt Paydown Yield | -0.01% |